DK1930414T3 - Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle - Google Patents

Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle

Info

Publication number
DK1930414T3
DK1930414T3 DK06797441.0T DK06797441T DK1930414T3 DK 1930414 T3 DK1930414 T3 DK 1930414T3 DK 06797441 T DK06797441 T DK 06797441T DK 1930414 T3 DK1930414 T3 DK 1930414T3
Authority
DK
Denmark
Prior art keywords
cell activation
antigen presenting
presenting cell
activating antigen
activating
Prior art date
Application number
DK06797441.0T
Other languages
English (en)
Inventor
Mie Nieda
Manami Isogai
Masashi Takahara
Andrew Nicol
Original Assignee
Medinet Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinet Co Ltd filed Critical Medinet Co Ltd
Application granted granted Critical
Publication of DK1930414T3 publication Critical patent/DK1930414T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/46449—Melanoma antigens
    • A61K39/464491—Melan-A/MART
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK06797441.0T 2005-09-08 2006-09-05 Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle DK1930414T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005295598 2005-09-08
JP2006112571 2006-04-14
PCT/JP2006/317535 WO2007029689A1 (ja) 2005-09-08 2006-09-05 抗原提示細胞の活性化処理方法

Publications (1)

Publication Number Publication Date
DK1930414T3 true DK1930414T3 (da) 2012-10-22

Family

ID=37835809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06797441.0T DK1930414T3 (da) 2005-09-08 2006-09-05 Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle

Country Status (9)

Country Link
US (2) US8609410B2 (da)
EP (1) EP1930414B1 (da)
JP (2) JP5384827B2 (da)
KR (1) KR101419711B1 (da)
CN (1) CN101258238B (da)
AU (1) AU2006288348B2 (da)
DK (1) DK1930414T3 (da)
ES (1) ES2391573T3 (da)
WO (1) WO2007029689A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2006006638A1 (ja) * 2004-07-08 2006-01-19 Medinet Co., Ltd 樹状細胞、該樹状細胞を含む医薬、該樹状細胞を用いた治療方法およびγδＴ細胞の培養方法
PT2311470E (pt) * 2008-07-01 2015-07-09 Medinet Co Ltd Método para indução simultânea de ctl e células gama delta
US10188733B2 (en) 2010-10-22 2019-01-29 President And Fellows Of Harvard College Vaccines comprising bisphosphonate and methods of use thereof
WO2013174403A1 (en) * 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2013174404A1 (en) * 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
JP6499079B2 (ja) 2012-11-13 2019-04-10 バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ クローディンを発現するガン疾患を処置するための剤
CN102994448A (zh) * 2012-12-13 2013-03-27 上海柯莱逊生物技术有限公司 一种体外扩增γδT细胞的方法
CN104651308A (zh) * 2013-11-22 2015-05-27 深圳先进技术研究院 一种用磷酸盐扩增γδT细胞的方法及其应用
JP2017524031A (ja) 2014-07-09 2017-08-24 ティーシー バイオファーム リミテッド ガンマデルタｔ細胞およびその使用
GB201506423D0 (en) 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
US10471141B2 (en) 2014-09-03 2019-11-12 Nitto Denko Corporation Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity
EP3189854B1 (en) 2014-09-03 2020-04-29 Nitto Denko Corporation Vaccine composition for transdermal or transmucosal administration
CN106190972A (zh) * 2015-04-30 2016-12-07 广州复大医疗股份有限公司 一种外周血γδT细胞的诱导扩增培养方法
KR20200060540A (ko) * 2015-09-09 2020-05-29 칭화 유니버시티 고-효율 백신 아쥬반트로서 메발로네이트 경로 억제제
EP3453755B1 (en) * 2016-04-28 2023-06-28 Riken Technology for efficient activation of nkt cells
CA3100200A1 (en) * 2018-05-21 2019-11-28 Nanostring Technologies, Inc. Molecular gene signatures and methods of using same
CN110272870A (zh) * 2019-05-16 2019-09-24 安徽瑞达健康产业有限公司 一种细胞组合物在癌细胞nci-h1975上的应用
CN112089840B (zh) * 2020-10-27 2022-04-12 中南大学湘雅三医院 Ktn1-as1的抑制剂在制备治疗膀胱癌药物中的应用
CN113755599B (zh) * 2021-10-14 2023-12-26 四川大学华西医院 Grb7基因在结直肠癌的诊断、预后检测评价和药物制备中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821778B1 (en) * 1993-12-01 2004-11-23 The Board Of Trustees Of Leland Stanford Junior University Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
US6429199B1 (en) * 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
GB0012209D0 (en) * 2000-05-19 2000-07-12 Novartis Ag Organic compounds
US20040014724A1 (en) * 2001-05-09 2004-01-22 Seaman John J. Method of administering a bisphosphonate
MXPA04001972A (es) * 2001-08-30 2005-02-17 3M Innovative Properties Co Metodos para hacer madurar celulas dendricas plasmacitoide utilizando moleculas modificadoras de respuesta enmune.
WO2006006638A1 (ja) * 2004-07-08 2006-01-19 Medinet Co., Ltd 樹状細胞、該樹状細胞を含む医薬、該樹状細胞を用いた治療方法およびγδＴ細胞の培養方法

Also Published As

Publication number Publication date
US20140073050A1 (en) 2014-03-13
EP1930414A4 (en) 2009-04-15
CN101258238A (zh) 2008-09-03
JP2013150609A (ja) 2013-08-08
US20090104161A1 (en) 2009-04-23
WO2007029689A1 (ja) 2007-03-15
US8609410B2 (en) 2013-12-17
ES2391573T3 (es) 2012-11-27
EP1930414A1 (en) 2008-06-11
CN101258238B (zh) 2014-07-09
JP5307944B2 (ja) 2013-10-02
AU2006288348A1 (en) 2007-03-15
EP1930414B1 (en) 2012-07-18
JP5384827B2 (ja) 2014-01-08
AU2006288348B2 (en) 2012-05-03
JPWO2007029689A1 (ja) 2009-03-19
KR101419711B1 (ko) 2014-07-17
KR20080059166A (ko) 2008-06-26

Similar Documents

Publication Publication Date Title
DK1930414T3 (da) Fremgangsmåde til aktiveringsbehandling af antigenpræsenterende celle
DK3494882T3 (da) Indretning til overvågning af analytter
FR2881809B1 (fr) Bloqueur de lacet rapide
FI20055649A0 (fi) Paikanmääritystekniikoita
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DE602007004421D1 (de) Zellkulturvorrichtung
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
DE602007008787D1 (de) Spannvorrichtung
DE602005017745D1 (de) Brennstoffzellen-auseinanderbauverfahren
DE112006000958B8 (de) Brennstoffzelle
DK1984744T3 (da) Fremgangsmåder og sæt til diagnostisering af væksthormonmangel
DE602006012891D1 (de) Brennstoffzellenseparator
DE602006013524D1 (de) Brennstoffzelle
FI20065363A0 (fi) Erotusmenetelmä
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.
DE502006007466D1 (de) Laser-Mikrodissektionsgerät
SE0501190L (sv) Tätningsorgan
DK1789800T3 (da) Ileitis-diagnosetest
DK2217376T3 (da) Kuvette og fremgangsmåde til anvendelse af denne kuvette
DE112007001674A5 (de) Spannvorrichtung
DK1931998T3 (da) Fremgangsmåde til kvantificering af allergener
DK2094728T3 (da) Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer
DE602006020338D1 (de) Brennstoffzelle